Use of microaxial flow pumps in adolescentsCentral MessagePerspective

Objectives: The Impella 5.5 has been successfully used in the adult population; however, safety and efficacy data in patients aged less than 18 years are limited. Methods: Six pediatric patients, aged 13 to 16 years and weighing 45 to 113 kg, underwent axillary artery graft placement and attempted p...

Full description

Bibliographic Details
Published in:JTCVS Techniques
Main Authors: Lauren E. Parker, BS, Douglas M. Overbey, MD, Lillian Kang, MD, Cathlyn K. Medina, BA, Leonie M. Kurzlechner, BS, Ziv Beckerman, MD, Nicholas D. Andersen, MD, Jacob N. Schroder, MD, Joseph Turek, MD, PhD, MBA
Format: Article
Language:English
Published: Elsevier 2023-10-01
Subjects:
cardiomyopathy
Impella 5.5
LVAD
pediatric heart failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2666250723002699

Internet

http://www.sciencedirect.com/science/article/pii/S2666250723002699

Similar Items